Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-01-25 @ 8:48 AM
Study NCT ID:
NCT04752059
Status:
COMPLETED
Last Update Posted:
2023-05-12
First Post:
2021-01-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases
Sponsor:
Medical University of Vienna
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TUXEDO-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |